Non-cell-autonomous tumor suppression: Oncogene-provoked apoptosis promotes tumor cell senescence via stromal crosstalk

Journal of Molecular Medicine

Volumn 89, Issue 9, 2011, Pages 869-875

  Reimann, Maurice ^a   Schmitt, Clemens A ^a,b   Lee, Soyoung ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

DLBCL; Lymphomagenesis; Macrophages; Senescence; TGF ; Tumor stroma

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; B CELL LYMPHOMA; CANCER INHIBITION; CELL POPULATION; CELLULAR STRESS RESPONSE; HUMAN; IMMUNOSURVEILLANCE; INNATE IMMUNITY; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; ONCOGENE MYC; PHAGOCYTOSIS; REVIEW; SENESCENCE; STROMA CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL;

ANIMALS; APOPTOSIS; CELL AGING; HUMANS; IMMUNE SYSTEM; MACROPHAGES; NEOPLASMS; ONCOGENE PROTEINS; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR MICROENVIRONMENT;

EID: 80052482250     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-011-0770-2     Document Type: Review

References (54)

1. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 10647931 10.1016/S0092-8674(00)81683-9 1:CAS:528:DC%2BD3cXks1CktA%3D%3D (Pubitemid 30046295)
2. CA Schmitt 2003 Senescence, apoptosis and therapy-cutting the lifelines of cancer Nat Rev Cancer 3 286 295 12671667 10.1038/nrc1044 1:CAS:528: DC%2BD3sXisFajt7Y%3D (Pubitemid 37328864)
3. Y Shi JM Glynn LJ Guilbert TG Cotter RP Bissonnette DR Green 1992 Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas Science 257 212 214 1378649 10.1126/science.1378649 1:CAS:528:DyaK38XltV2qtrc%3D
4. GI Evan AH Wyllie CS Gilbert TD Littlewood H Land M Brooks CM Waters LZ Penn DC Hancock 1992 Induction of apoptosis in fibroblasts by c-myc protein Cell 69 119 128 1555236 10.1016/0092-8674(92)90123-T 1:CAS:528:DyaK38Xitlaqtr0%3D
5. INK4a Cell 88 593 602 9054499 10.1016/S0092-8674(00)81902-9 1:CAS:528:DyaK2sXhvVSit7k%3D (Pubitemid 27152402)
6. M Braig S Lee C Loddenkemper C Rudolph AH Peters B Schlegelberger H Stein B Dörken T Jenuwein CA Schmitt 2005 Oncogene-induced senescence as an initial barrier in lymphoma development Nature 436 660 665 16079837 10.1038/nature03841 1:CAS:528:DC%2BD2MXmvFentbY%3D (Pubitemid 41117262)
7. M Burnet 1957 Cancer: a biological approach. I. The processes of control Br Med J 1 779 786 13404306 10.1136/bmj.1.5022.779 1:STN:280: DyaG2s%2FltVGrug%3D%3D
8. G Parmiani A De Filippo L Novellino C Castelli 2007 Unique human tumor antigens: immunobiology and use in clinical trials J Immunol 178 1975 1979 17277099 1:CAS:528:DC%2BD2sXht1CgtLc%3D (Pubitemid 46233392)
9. SP Cullen M Brunet SJ Martin 2010 Granzymes in cancer and immunity Cell Death Differ 17 616 623 20075940 10.1038/cdd.2009.206 1:CAS:528: DC%2BC3cXjt1OgsLg%3D
10. I Waldhauer A Steinle 2008 NK cells and cancer immunosurveillance Oncogene 27 5932 5943 18836474 10.1038/onc.2008.267 1:CAS:528:DC%2BD1cXhtF2msbnE
11. JD Bui RD Schreiber 2007 Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? Curr Opin Immunol 19 203 208 17292599 10.1016/j.coi.2007.02.001 1:CAS:528:DC%2BD2sXisleiu7c%3D (Pubitemid 46356963)
12. LA O' Reilly L Tai L Lee EA Kruse S Grabow WD Fairlie NM Haynes DM Tarlinton JG Zhang GT Belz, et al. 2009 Membrane-bound Fas ligand only is essential for Fas-induced apoptosis Nature 461 659 663 19794494 10.1038/nature08402
13. MJ Smyth K Takeda Y Hayakawa JJ Peschon MR van den Brink H Yagita 2003 Nature's TRAIL-on a path to cancer immunotherapy Immunity 18 1 6 12530970 10.1016/S1074-7613(02)00502-2 1:CAS:528:DC%2BD3sXnvVykuw%3D%3D (Pubitemid 36120682)
14. S Jaiswal CH Jamieson WW Pang CY Park MP Chao R Majeti D Traver N van Rooijen IL Weissman 2009 CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells Cell 138 271 285 19632178 10.1016/j.cell.2009.05.046 1:CAS:528:DC%2BD1MXhtVSgtr3M
15. GP Dunn CM Koebel RD Schreiber 2006 Interferons, immunity and cancer immunoediting Nat Rev Immunol 6 836 848 17063185 10.1038/nri1961 1:CAS:528:DC%2BD28XhtFWns7fK (Pubitemid 44631652)
16. V Shankaran H Ikeda AT Bruce JM White PE Swanson LJ Old RD Schreiber 2001 IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity Nature 410 1107 1111 11323675 10.1038/35074122 1:CAS:528:DC%2BD3MXjsVCrtr4%3D (Pubitemid 32391043)
17. K Lauber E Bohn SM Kröber YJ Xiao SG Blumenthal RK Lindemann P Marini C Wiedig A Zobywalski S Baksh, et al. 2003 Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal Cell 113 717 730 12809603 10.1016/S0092-8674(03)00422-7 1:CAS:528:DC%2BD3sXkvVekt7k%3D (Pubitemid 36724936)
18. A Krtolica S Parrinello S Lockett PY Desprez J Campisi 2001 Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging Proc Natl Acad Sci U S A 98 12072 12077 11593017 10.1073/pnas.211053698 1:CAS:528:DC%2BD3MXns1CjsLw%3D (Pubitemid 32959828)
19. S Parrinello JP Coppe A Krtolica J Campisi 2005 Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation J Cell Sci 118 Pt 3 485 496 15657080 10.1242/jcs.01635 1:CAS:528:DC%2BD2MXhvFKntb0%3D (Pubitemid 40310116)
20. JP Coppé K Kauser J Campisi CM Beauséjour 2006 Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence J Biol Chem 281 29568 29574 16880208 10.1074/jbc.M603307200 (Pubitemid 44536964)
21. JP Coppé PY Desprez A Krtolica J Campisi 2010 The senescence-associated secretory phenotype: the dark side of tumor suppression Annu Rev Pathol 5 99 118 20078217 10.1146/annurev-pathol-121808-102144
22. W Xue L Zender C Miething RA Dickins E Hernando V Krizhanovsky C Cordon-Cardo SW Lowe 2007 Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas Nature 445 656 660 17251933 10.1038/nature05529 1:CAS:528:DC%2BD2sXhtlOrtbo%3D (Pubitemid 46232886)
23. JC Acosta A O'Loghlen A Banito MV Guijarro A Augert S Raguz M Fumagalli M Da Costa C Brown N Popov, et al. 2008 Chemokine signaling via the CXCR2 receptor reinforces senescence Cell 133 1006 1018 18555777 10.1016/j.cell.2008. 03.038 1:CAS:528:DC%2BD1cXnsF2gtbo%3D (Pubitemid 351795610)
24. N Wajapeyee RW Serra X Zhu M Mahalingam MR Green 2008 Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7 Cell 132 363 374 18267069 10.1016/j.cell.2007.12.032 1:CAS:528:DC%2BD1cXivVahtbc%3D (Pubitemid 351191995)
25. C Kuilman LC Michaloglou S Vredeveld R Douma CJ van Doorn LA Desmet WJ Aarden WJ Mooi DS Peeper 2008 Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network Cell 133 1019 1031 18555778 10.1016/j.cell.2008.03.039 1:CAS:528:DC%2BD1cXnsF2gtbs%3D (Pubitemid 351787746)
26. AR Young M Narita M Ferreira K Kirschner M Sadaie JF Darot S Tavaré S Arakawa S Shimizu FM Watt, et al. 2009 Autophagy mediates the mitotic senescence transition Genes Dev 23 798 803 19279323 10.1101/gad.519709 1:CAS:528:DC%2BD1MXks1SrtbY%3D
27. S Yousefi R Perozzo I Schmid A Ziemiecki T Schaffner L Scapozza T Brunner HU Simon 2006 Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis Nat Cell Biol 8 1124 1132 16998475 10.1038/ncb1482 1:CAS:528:DC%2BD28XhtVWqsLfP (Pubitemid 44473608)
28. MC Maiuri E Zalckvar A Kimchi G Kroemer 2007 Self-eating and self-killing: crosstalk between autophagy and apoptosis Nat Rev Mol Cell Biol 8 741 752 17717517 10.1038/nrm2239 1:CAS:528:DC%2BD2sXpsVartb8%3D (Pubitemid 47312826)
29. X Qu Z Zou Q Sun K Luby-Phelps P Cheng RN Hogan C Gilpin B Levine 2007 Autophagy gene-dependent clearance of apoptotic cells during embryonic development Cell 128 931 946 17350577 10.1016/j.cell.2006.12.044 1:CAS:528:DC%2BD2sXjvVSgu7c%3D (Pubitemid 46341412)
30. M Reimann S Lee C Loddenkemper JR Dörr V Tabor P Aichele H Stein B Dörken T Jenuwein CA Schmitt 2010 Tumor stroma-derived TGF-β limits myc-driven lymphomagenesis via Suv39h1-dependent senescence Cancer Cell 17 262 272 20227040 10.1016/j.ccr.2009.12.043 1:CAS:528:DC%2BC3cXlsVWqtLc%3D
31. G Lenz G Wright SS Dave W Xiao J Powell H Zhao W Xu B Tan N Goldschmidt J Iqbal Lymphoma/Leukemia Molecular Profiling Project, et al. 2008 Stromal gene signatures in large-B-cell lymphomas N Engl J Med 359 2313 2323 19038878 10.1056/NEJMoa0802885 1:CAS:528:DC%2BD1cXhsVehtbvF
32. SS Dave G Wright B Tan A Rosenwald RD Gascoyne WC Chan RI Fisher RM Braziel LM Rimsza TM Grogan, et al. 2004 Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells N Engl J Med 351 2159 2169 15548776 10.1056/NEJMoa041869 1:CAS:528:DC%2BD2cXhtVSqtL%2FP (Pubitemid 39507628)
33. DA Thomas J Massagué 2005 TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance J Cancer Cell 8 369 380 10.1016/j.ccr.2005.10.012 1:CAS:528:DC%2BD2MXht12gsbvK (Pubitemid 41579832)
34. JN Rich M Zhang MB Datto DD Bigner XF Wang 1999 Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines J Biol Chem 274 35053 35058 10574984 10.1074/jbc.274.49.35053 1:CAS:528: DyaK1MXnvFyrtL0%3D (Pubitemid 129509557)
35. JM Scandura P Boccuni J Massagué SD Nimer 2004 Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation Proc Natl Acad Sci U S A 101 15231 15236 15477587 10.1073/pnas.0406771101 1:CAS:528:DC%2BD2cXpsVSgtbY%3D (Pubitemid 39391747)
36. J Seoane HV Le L Shen SA Anderson J Massagué 2004 Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation Cell 117 211 223 15084259 10.1016/S0092-8674(04)00298-3 1:CAS:528:DC%2BD2cXjsFyrurc%3D (Pubitemid 38496241)
37. J Massagué 2008 TGFbeta in cancer Cell 134 215 230 18662538 10.1016/j.cell.2008.07.001 (Pubitemid 352010335)
38. J van Riggelen J Müller T Otto V Beuger A Yetil PS Choi C Kosan T Möröy DW Felsher M Eilers 2010 The interaction between Myc and Miz1 is required to antagonize TGF β-dependent autocrine signaling during lymphoma formation and maintenance Genes Dev 24 12 1281 1294 20551174 10.1101/gad.585710
39. F Balkwill KA Charles A Mantovani 2005 Smoldering and polarized inflammation in the initiation and promotion of malignant disease Cancer Cell 7 211 217 15766659 10.1016/j.ccr.2005.02.013 1:CAS:528:DC%2BD2MXivFCqurk%3D (Pubitemid 40568680)
40. A Mantovani A Sica S Sozzani P Allavena A Vecchi M Locati 2004 The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol 25 677 686 15530839 10.1016/j.it.2004.09.015 1:CAS:528: DC%2BD2cXptl2ktbs%3D (Pubitemid 39457982)
41. S Gordon 2003 Alternative activation of macrophages Nat Rev Immunol 3 23 35 12511873 10.1038/nri978 1:CAS:528:DC%2BD3sXovVw%3D (Pubitemid 37328697)
42. A Sica T Schioppa A Mantovani P Allavena 2006 Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy Eur J Cancer 42 717 727 16520032 10.1016/j.ejca.2006.01.003 1:CAS:528:DC%2BD28Xjs1Grt78%3D
43. SM Zeisberger B Odermatt C Marty AH Zehnder-Fjällman K Ballmer-Hofer RA Schwendener 2006 Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach Br J Cancer 95 272 281 16832418 10.1038/sj.bjc.6603240 1:CAS:528:DC%2BD28Xnsl2iu7o%3D (Pubitemid 44187587)
44. S Hasselblom U Hansson M Sigurdardottir H Nilsson-Ehle B Ridell PO Andersson 2008 Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis Pathol Int 58 8 529 532 18705775 10.1111/j.1440-1827.2008.02268.x (Pubitemid 351952031)
45. K Rakhra P Bachireddy T Zabuawala R Zeiser L Xu A Kopelman AC Fan Q Yang L Braunstein E Crosby S Ryeom DW Felsher 2010 CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation Cancer Cell 18 5 485 498 21035406 10.1016/j.ccr.2010.10. 002 1:CAS:528:DC%2BC3cXhsValtLrI
46. + T cells Immunity 22 371 383 15780993 10.1016/j.immuni.2005.02.003 1:CAS:528:DC%2BD2MXjt1Ohtr4%3D (Pubitemid 40387478)
47. M Reimann C Loddenkemper C Rudolph I Schildhauer B Teichmann H Stein B Schlegelberger B Dörken CA Schmitt 2007 The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo Blood 110 2996 3004 17562874 10.1182/blood-2007-02-075614 1:CAS:528:DC%2BD2sXht1Smu7%2FI (Pubitemid 350006954)
48. L Griffiths K Binley S Iqball O Kan P Maxwell P Ratcliffe C Lewis A Harris S Kingsman S Naylor 2000 The macrophage-a novel system to deliver gene therapy to pathological hypoxia Gene Ther 7 255 262 10694803 10.1038/sj.gt.3301058 1:CAS:528:DC%2BD3cXhtlyjsrY%3D (Pubitemid 30113775)
49. L Carta S Pastorino G Melillo MC Bosco S Massazza L Varesio 2001 Engineering of macrophages to produce IFN-γ in response to hypoxia J Immunol 166 5374 5380 11313373 1:CAS:528:DC%2BD3MXjtFyrtL4%3D (Pubitemid 32374156)
50. B Burke S Sumner N Maitland CE Lewis 2002 Macrophages in gene therapy: cellular delivery vehicles and in vivo targets J Leukoc Biol 72 417 428 12223508 1:CAS:528:DC%2BD38XntlOnurg%3D
51. C Guiducci AP Vicari S Sangaletti G Trinchieri MP Colombo 2005 Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection Cancer Res 65 3437 3446 15833879 1:CAS:528: DC%2BD2MXjt1yrtr8%3D (Pubitemid 40524630)
52. T Hagemann T Lawrence I McNeish KA Charles H Kulbe RG Thompson SC Robinson FR Balkwill 2008 Re-educating tumor-associated macrophages by targeting NF-kappaB J Exp Med 205 1261 1268 18490490 10.1084/jem.20080108 1:CAS:528:DC%2BD1cXntFansbk%3D (Pubitemid 351831483)
53. P Sinha VK Clements S Ostrand-Rosenberg 2005 Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease J Immunol 174 636 645 15634881 1:CAS:528:DC%2BD2MXotFSg (Pubitemid 40094255)
54. MJ Rauh LM Sly J Kalesnikoff MR Hughes LP Cao V Lam G Krystal 2004 The role of SHIP1 in macrophage programming and activation Biochem Soc Trans 32 Pt 5 785 788 15494015 1:CAS:528:DC%2BD2cXptVSls7c%3D (Pubitemid 39524379)